EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
Angela E Rankine-Mullings
1
, MBBS, MRCPCH
;
Courtney R Little
2
, RN, BSN
;
Marvin E Reid
3
, MBBS, PhD
;
Deanne P Soares
3
, MBBS, DM
;
Carolyn Taylor-Bryan
3
, MBBS, DM
;
Jennifer M Knight-Madden
1
, MBBS, PhD
;
Susan E Stuber
2
, MA
;
Asha V Badaloo
3
, PhD
;
Karen Aldred
1
, MSc
;
Margaret E Wisdom-Phipps
1
, RN, RM
;
Teresa Latham
2
, MA
;
Russell E Ware
2
, MD, PhD
1
Sickle Cell Unit
,
Tropical Medicine Research Institute
,
University of the West Indies
,
Kingston
,
JM
2
Division of Hematology
,
Cincinnati Children’s Hospital Medical Center
,
Cincinnati
,
OH
,
US
3
Tropical Metabolism Research Unit
,
Tropical Medicine Research Institute
,
University of the West Indies
,
Kingston
,
JM